Beta Drugs shares surge over 4% after acquiring stake in Nivian

Beta Drugs Ltd shares surged over 4% following the company's announcement of acquiring a controlling stake in IVF specialist Nivian Lifesciences. Beta Drugs has signed a definitive agreement to acquire a 66.09% controlling stake in Nivian Lifesciences Pvt Ltd from existing shareholders. It marks Beta Drugs' first entry into the women's health and fertility drug segment.